Immunopathogenesis of inflammatory bowel disease

Por Shih, David Q, Targan, Stephan R
Publicado em 2008

Insights into IBD Pathogenesis

Por Shih, David Q., Targan, Stephan R.
Publicado em 2009

Future Therapeutic Approaches for Inflammatory Bowel Diseases

Por Plevy, Scott E., Targan, Stephan R.
Publicado no Gastroenterology (2011)

Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells.

Por Deem, R L, Shanahan, F, Targan, S R
Publicado em 1991

Inflammatory bowel disease from bench to bedside /

Por Targan, Stephan R., Shanahan, Fergus., Karp, Loren C.
Publicado em 2005

Distinct Methylation of IFNG in the Gut

Por Gonsky, Rivkah, Deem, Richard L., Targan, Stephan R.
Publicado em 2009

Multiple activating and repressive cis-promoter regions regulate TNFSF15 expression in human primary mononuclear cells

Por Gonsky, Rivkah, Deem, Richard L., Targan, Stephan R.
Publicado em 2013

Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD

Por Jacob, Noam, Targan, Stephan R, Shih, David Q
Publicado no United European Gastroenterol J (2016)

The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.

Por Deem, R L, Targan, S R, Niederlehner, A, Shanahan, F
Publicado em 1990

Recent Advances in IBD Pathogenesis: Genetics and Immunobiology

Por Shih, David Q., Targan, Stephan R., McGovern, Dermot
Publicado em 2008

A case of steroid-dependent myeloid granulocytic sarcoma masquerading as Crohn’s disease

Por Kwan, Lola Y, Targan, Stephan R, Shih, David Q
Publicado em 2011

Microbiota activation and regulation of innate and adaptive immunity

Por Alexander, Katie L., Targan, Stephan R., Elson, Charles O.
Publicado em 2014

Differential levels of Tl1a affect the expansion and function of regulatory T cells in modulating murine colitis

Por Sidhu-Varma, Maninder, Shih, David Q., Targan, Stephan R.
Publicado no Inflamm Bowel Dis (2016)

Immunogenetic phenotypes in inflammatory bowel disease

Por Dubinsky, Marla C, Taylor, Kent, Targan, Stephan R, Rotter, Jerome I
Publicado em 2006

Therapeutic Targets for Emerging Biologic Therapies in IBD

Por Hanauer, Stephen B., Plevy, Scott E., Sands, Bruce E., Targan, Stephan R.
Publicado em 2009

CD161 defines effector T cells that express light and respond to TL1A-DR3 signaling

Por Cohavy, O., Shih, D. Q., Doherty, T. M., Ware, C. F., Targan, S. R.
Publicado em 2011

Enhanced CBir1-specific innate and adaptive immune responses in Crohn’s disease

Por Shen, Chong, Landers, Carol J., Derkowski, Carrie, Elson, Charles O., Targan, Stephan R.
Publicado em 2008

TNFSF15 is an Ethnic Specific IBD Gene

Por Picornell, Yoana, Mei, Ling, Taylor, Kent, Yang, Huiying, Targan, Stephan R., Rotter, Jerome I.
Publicado em 2007

TLR8-mediated activation of human monocytes inhibits TL1A expression

Por Saruta, Masayuki, Michelsen, Kathrin S., Thomas, Lisa S., Yu, Qi T., Landers, Carol J., Targan, Stephan R.
Publicado em 2009

HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T cell proliferation and T(H)1/T(H)17 responses

Por Michelsen, Kathrin S., Wong, Michelle H., Ko, Brian, Thomas, Lisa S., Dhall, Deepti, Targan, Stephan R.
Publicado no Inflamm Bowel Dis (2013)